BOK Financial Private Wealth’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21K Sell
1,022
-766
-43% -$17.5K ﹤0.01% 341
2026
Q1
$39.4K Hold
1,788
﹤0.01% 288
2025
Q4
$21.1K Hold
1,788
﹤0.01% 351
2025
Q3
$28.3K Hold
1,788
﹤0.01% 286
2025
Q2
$20.5K Sell
1,788
-3,137
-64% -$35.3K ﹤0.01% 319
2025
Q1
$66.6K Hold
4,925
0.01% 241
2024
Q4
$83.2K Sell
4,925
-340
-6% -$6.62K 0.01% 222
2024
Q3
$107K Sell
5,265
-200
-4% -$4.09K 0.01% 205
2024
Q2
$123K Hold
5,465
0.01% 192
2024
Q1
$144K Hold
5,465
0.01% 186
2023
Q4
$172K Hold
5,465
0.01% 172
2023
Q3
$153K Hold
5,465
0.01% 169
2023
Q2
$202K Hold
5,465
0.02% 155
2023
Q1
$164K Hold
5,465
0.01% 167
2022
Q4
$167K Buy
5,465
+766
+16% +$23K 0.01% 165
2022
Q3
$116K Hold
4,699
0.01% 193
2022
Q2
$150K Buy
+4,699
New +$173K 0.01% 186

Other funds holding CC

BOK Financial Private Wealth's CC Position: Q2 2026 in Review

BOK Financial Private Wealth reduced its Chemours (CC) stake by 43% in Q2 2026, selling an estimated $17.5K and leaving 1,022 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #341.

BOK Financial Private Wealth first reported a position in CC in Q2 2022 and has held it in 17 quarters since. The position peaked at $202K in Q2 2023. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • BOK Financial Private Wealth held 1,022 shares of Chemours worth $21K as of Q2 2026.
  • BOK Financial Private Wealth sold 766 Chemours shares in Q2 2026, an estimated $17.5K.
  • Chemours made up ﹤0.01% of BOK Financial Private Wealth's portfolio in Q2 2026, its #341 holding.
  • BOK Financial Private Wealth first reported a position in Chemours in Q2 2022 and has held it in 17 quarters since.
  • BOK Financial Private Wealth's Chemours position peaked at $202K in Q2 2023.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on BOK Financial Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.